Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 221

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols

Hwang, Jin-Taek, Kwon, Dae Young, Yoon, Suk Hoo·2009·New Biotechnology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbt.2009.03.005

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 72

  1. Hardie, 2007, AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy, Nat. Rev. Mol. Cell Biol., 8, 774, 10.1038/nrm2249 · DOI · Paper page
  2. Hawley, 2003, Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade, J. Biol., 2, 28, 10.1186/1475-4924-2-28 · DOI · Paper page
  3. Day, 2007, Structure of a CBS-domain pair from the regulatory gamma1 subunit of human AMPK in complex with AMP and ZMP, Acta. Crystallogr. D. Biol. Crystallogr., 63, 587, 10.1107/S0907444907009110 · DOI
  4. Wong, 2006, A revised model for AMP-activated protein kinase structure: the alpha-subunit binds to both the beta- and gamma-subunits although there is no direct binding between the beta- and gamma-subunits, J. Biol. Chem., 281, 36434, 10.1074/jbc.M607410200 · DOI
  5. Carling, 2005, AMP-activated protein kinase: balancing the scales, Biochimie, 87, 87, 10.1016/j.biochi.2004.10.017 · DOI · Paper page
  6. Hardie, 2004, The AMP-activated protein kinase pathway—new players upstream and downstream, J. Cell Sci., 117, 5479, 10.1242/jcs.01540 · DOI · Paper page
  7. Young, 2005, AMP-activated protein kinase: a key stress signaling pathway in the heart, Trends Cardiovasc. Med., 15, 110, 10.1016/j.tcm.2005.04.005 · DOI · Paper page
  8. Hue, 2003, New targets of AMP-activated protein kinase, Biochem. Soc. Trans., 31, 213, 10.1042/bst0310213 · DOI
  9. Hardie, 2005, New roles for the LKB1→AMPK pathway, Curr. Opin. Cell Biol., 17, 167, 10.1016/j.ceb.2005.01.006 · DOI · Paper page
  10. Rattan, 2005, 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase, J. Biol. Chem., 280, 39582, 10.1074/jbc.M507443200 · DOI · Paper page
  11. Xiang, 2004, AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms, Biochem. Biophys. Res. Commun., 321, 161, 10.1016/j.bbrc.2004.06.133 · DOI · Paper page
  12. Guan, 2007, AICAR inhibits proliferation and induced S-phase arrest, and promotes apoptosis in CaSki cells, Acta. Pharmacol. Sin., 28, 1984, 10.1111/j.1745-7254.2007.00675.x · DOI
  13. Viollet, 2007, Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders, Diabetes Metab., 33, 395, 10.1016/j.diabet.2007.10.004 · DOI · Paper page
  14. Steinberg, 2007, The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity, Mini Rev. Med. Chem., 7, 519, 10.2174/138955707780619662 · DOI
  15. Cartee, 2007, Role of Akt substrate of 160kDa in insulin-stimulated and contraction-stimulated glucose transport, Appl. Physiol. Nutr. Metab., 32, 557, 10.1139/H07-026 · DOI · Paper page
  16. Tomas, 2002, Hyperglycemia and insulin resistance: possible mechanisms, Ann. N. Y. Acad. Sci., 967, 43, 10.1111/j.1749-6632.2002.tb04262.x · DOI · Paper page
  17. Sarbassov, 2005, Growing roles for the mTOR pathway, Curr. Opin. Cell Biol., 17, 596, 10.1016/j.ceb.2005.09.009 · DOI · Paper page
  18. Dray, 2008, Apelin stimulates glucose utilization in normal and obese insulin-resistant mice, Cell Metab., 8, 437, 10.1016/j.cmet.2008.10.003 · DOI · Paper page
  19. Saha, 2003, Malonyl-CoA and AMP-activated protein kinase: an expanding partnership, Mol. Cell Biochem., 253, 65, 10.1023/A:1026053302036 · DOI · Paper page
  20. Hardie, 2002, Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase, Biochem. Soc. Trans., 30, 1064, 10.1042/bst0301064 · DOI · Paper page
  21. Kim, 2008, Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose tissue of rats, Biol. Pharm. Bull., 31, 1415, 10.1248/bpb.31.1415 · DOI
  22. Ching, 1996, Analysis of the specificity of the AMP-activated protein kinase by site-directed mutagenesis of bacterially expressed 3-hydroxy 3-methylglutaryl-CoA reductase, using a single primer variant of the unique-site-elimination method, Eur. J. Biochem., 237, 800, 10.1111/j.1432-1033.1996.0800p.x · DOI
  23. Pallottini, 2004, Mechanisms underlying the impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver, Mech. Ageing Dev., 125, 633, 10.1016/j.mad.2004.08.001 · DOI
  24. Hadad, 2008, Targeting AMPK: a new therapeutic opportunity in breast cancer, Crit. Rev. Oncol. Hematol., 67, 1, 10.1016/j.critrevonc.2008.01.007 · DOI
  25. Rosner, 2008, The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners, Mutat. Res., 658, 234, 10.1016/j.mrrev.2008.01.001 · DOI
  26. Motoshima, 2006, AMPK and cell proliferation—AMPK as a therapeutic target for atherosclerosis and cancer, J. Physiol., 574, 63, 10.1113/jphysiol.2006.108324 · DOI · Paper page
  27. Dolinsky, 2006, Role of AMP-activated protein kinase in healthy and diseased hearts, Am. J. Physiol. Heart Circ. Physiol., 291, H2557, 10.1152/ajpheart.00329.2006 · DOI
  28. Davies, 2006, Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome, Am. J. Physiol. Heart Circ. Physiol., 290, H1942, 10.1152/ajpheart.01020.2005 · DOI
  29. Schwartz, 2007, Tuberous sclerosis complex: advances in diagnosis, genetics, and management, J. Am. Acad. Dermatol., 57, 189, 10.1016/j.jaad.2007.05.004 · DOI · Paper page
  30. Rosner, 2008, The mTOR pathway and its role in human genetic diseases, Mutat. Res., 659, 284, 10.1016/j.mrrev.2008.06.001 · DOI · Paper page
  31. Cheng, 2004, Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status, J. Biol. Chem., 279, 5719, 10.1074/jbc.C300534200 · DOI · Paper page
  32. Pedersen, 2007, IL-6 signalling in exercise and disease, Biochem. Soc. Trans., 35, 1295, 10.1042/BST0351295 · DOI · Paper page
  33. Carey, 2006, Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase, Diabetes, 55, 2688, 10.2337/db05-1404 · DOI · Paper page
  34. Watt, 2006, CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK, Nat. Med., 12, 541, 10.1038/nm1383 · DOI · Paper page
  35. Hwang, 2007, Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway, Cancer Lett., 247, 115, 10.1016/j.canlet.2006.03.030 · DOI · Paper page
  36. Collins, 2007, Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase, J. Biol. Chem., 282, 30143, 10.1074/jbc.M702390200 · DOI · Paper page
  37. Jung, 2008, Epigallocatechin gallate stimulates glucose uptake through the phosphatidylinositol 3-kinase-mediated pathway in L6 rat skeletal muscle cells, J. Med. Food, 11, 429, 10.1089/jmf.2007.0107 · DOI
  38. Hwang, 2005, Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase, Biochem. Biophys. Res. Commun., 338, 694, 10.1016/j.bbrc.2005.09.195 · DOI · Paper page
  39. Fan, 2008, Molecular mechanism of apoptosis induction by resveratrol, a natural cancer chemopreventive agent, Int. J. Vitam. Nutr. Res., 78, 3, 10.1024/0300-9831.78.1.3 · doi:10.1024/0300-9831.78.1.3
  40. Jiang, 2008, Sirtuins: novel targets for metabolic disease in drug development, Biochem. Biophys. Res. Commun., 373, 341, 10.1016/j.bbrc.2008.06.048 · DOI
  41. Tian, 2006, Inhibition of fatty acid synthase by polyphenols, Curr. Med. Chem., 13, 967, 10.2174/092986706776361012 · DOI
  42. Breen, 2008, Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK, Biochem. Biophys. Res. Commun., 374, 117, 10.1016/j.bbrc.2008.06.104 · DOI · Paper page
  43. Park, 2007, Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase, Exp. Mol. Med., 39, 222, 10.1038/emm.2007.25 · DOI · Paper page
  44. Penumathsa, 2008, Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/AKT/eNOS signaling pathway in diabetic myocardium, J. Cell Mol. Med., 10.1111/j.1582-4934.2008.00251.x · DOI · Paper page
  45. Zang, 2006, Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice, Diabetes, 55, 2180, 10.2337/db05-1188 · DOI · Paper page
  46. Palasciano, 2007, Non-alcoholic fatty liver disease in the metabolic syndrome, Curr. Pharm. Des., 13, 2193, 10.2174/138161207781039652 · DOI
  47. Shang, 2008, Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase, Acta. Pharmacol. Sin., 29, 698, 10.1111/j.1745-7254.2008.00807.x · DOI · Paper page
  48. Ajmo, 2008, Resveratrol alleviates alcoholic fatty liver in mice, Am. J. Physiol. Gastrointest. Liver Physiol., 295, G833, 10.1152/ajpgi.90358.2008 · DOI · Paper page
  49. Gerhauser, 2008, Cancer chemopreventive potential of apples, apple juice, and apple components, Planta Med., 74, 1608, 10.1055/s-0028-1088300 · DOI · Paper page
  50. Ahn, 2008, The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways, Biochem. Biophys. Res. Commun., 373, 545, 10.1016/j.bbrc.2008.06.077 · DOI · Paper page
  51. Fang, 2008, Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity, Life Sci., 82, 11, 10.1016/j.lfs.2007.12.021 · DOI · Paper page
  52. Lee, 2005, Radioprotective potential of ginseng, Mutagenesis, 20, 237, 10.1093/mutage/gei041 · DOI · Paper page
  53. Hwang, 2007, Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte, Biochem. Biophys. Res. Commun., 364, 1002, 10.1016/j.bbrc.2007.10.125 · DOI · Paper page
  54. Xie, 2005, Anti-diabetic effect of ginsenoside Re in ob/ob mice, Biochim. Biophys. Acta, 1740, 319, 10.1016/j.bbadis.2004.10.010 · DOI
  55. Park, 2005, Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide, Biol. Pharm. Bull., 28, 652, 10.1248/bpb.28.652 · DOI · Paper page
  56. Park, 2008, 20(S)-ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK, Biol. Pharm. Bull., 31, 748, 10.1248/bpb.31.748 · DOI
  57. Ferguson, 2007, Cancer prevention by dietary bioactive components that target the immune response, Curr. Cancer Drug Targets, 7, 459, 10.2174/156800907781386605 · DOI
  58. Menon, 2007, Antioxidant and anti-inflammatory properties of curcumin, Adv. Exp. Med. Biol., 595, 105, 10.1007/978-0-387-46401-5_3 · DOI · Paper page
  59. Pan, 2008, AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells, Oncol. Rep., 20, 1553
  60. Lee, 2009, Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells, J. Agric. Food Chem., 57, 305, 10.1021/jf802737z · DOI · Paper page
  61. Lee, 2007, CAPE (caffeic acid phenethyl ester) stimulates glucose uptake through AMPK (AMP-activated protein kinase) activation in skeletal muscle cells, Biochem. Biophys. Res. Commun., 361, 854, 10.1016/j.bbrc.2007.07.068 · DOI
  62. Arayne, 2007, The berberis story: Berberis vulgaris in therapeutics, Pak. J. Pharm. Sci., 20, 83
  63. Yin, 2008, Traditional chinese medicine in treatment of metabolic syndrome, Endocr. Metab. Immune. Disord. Drug Targets, 8, 99, 10.2174/187153008784534330 · DOI · Paper page
  64. Serafim, 2008, Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line, Cancer Chemother. Pharmacol., 61, 1007, 10.1007/s00280-007-0558-9 · DOI
  65. Park, 2006, Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents, Bioorg. Med. Chem. Lett., 16, 3913, 10.1016/j.bmcl.2006.05.033 · DOI
  66. Liang, 2008, Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells, Eur. J. Pharmacol., 590, 343, 10.1016/j.ejphar.2008.06.034 · DOI
  67. Kim, 2007, Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes, Biol. Pharm. Bull., 30, 2120, 10.1248/bpb.30.2120 · DOI
  68. Cheng, 2006, Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK, Biochim. Biophys. Acta, 1760, 1682, 10.1016/j.bbagen.2006.09.007 · DOI · Paper page
  69. Lee, 2006, Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states, Diabetes, 55, 2256, 10.2337/db06-0006 · DOI · Paper page
  70. Brusq, 2006, Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine, J. Lipid Res., 47, 1281, 10.1194/jlr.M600020-JLR200 · DOI · Paper page
  71. Lin, 2007, Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells, J. Lipid Res., 48, 2334, 10.1194/jlr.M700128-JLR200 · DOI · Paper page
  72. Park, 2008, Resveratrol downregulates Acetyl-CoA carboxylase α and fatty acid synthase by AMPK-mediated downregulation of mTOR in breast cancer cells, Food Sci. Biotechnol., 17, 1047

Cited by

See all 221

Metadata

Authors
Hwang, J.-T., Kwon, D. Y., & Yoon, S. H.
Venue
New Biotechnology
Publisher
Elsevier BV
Published
2009-10
Volume
26
Issue
1-2
Pages
17-22
ISSN
1871-6784 (ISSN-L)
OpenAlex
W2043498277
Cited by
221
References
3
FWCI
7.08
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Korea Science and Engineering Foundation
  • Ministry of Science and Technology, Pakistan
  • Korea Research Council for Industrial Science and Technology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. https://app.cochat.ai/papers/10.1016/j.nbt.2009.03.005
The paper
Hwang, J.-T., Kwon, D. Y., & Yoon, S. H. (2009). AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. New Biotechnology. https://doi.org/10.1016/j.nbt.2009.03.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.